These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 10342343

  • 21. Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.
    Rader DJ, Davidson MH, Caplan RJ, Pears JS.
    Am J Cardiol; 2003 Mar 06; 91(5A):20C-23C; discussion 23C-24C. PubMed ID: 12646340
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia.
    Raskin P, Ganda OP, Schwartz S, Willard D, Rosenstock J, Lodewick PA, Cressman MD, Phillipson B, Weiner B, McGovern ME.
    Am J Med; 1995 Oct 06; 99(4):362-9. PubMed ID: 7573090
    [Abstract] [Full Text] [Related]

  • 23. Pravastatin and risk factor modification in patients with moderate primary hypercholesterolaemia.
    Morris R, Robinson G, Tilyard M, Gurr E.
    N Z Med J; 1996 Aug 23; 109(1028):319-22. PubMed ID: 8816723
    [Abstract] [Full Text] [Related]

  • 24. Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin.
    Muramatsu J, Kobayashi A, Hasegawa N, Yokouchi S.
    Atherosclerosis; 1997 Apr 23; 130(1-2):179-82. PubMed ID: 9126662
    [Abstract] [Full Text] [Related]

  • 25. Effect of pravastatin on plasma ketone bodies in diabetics with hypercholesterolemia.
    Sato T, Oouchi M, Nagakubo H, Chiba T, Ogawa S, Sato C, Sugimura K, Fukuda M.
    Tohoku J Exp Med; 1998 May 23; 185(1):25-9. PubMed ID: 9710942
    [Abstract] [Full Text] [Related]

  • 26. Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin.
    Contacos C, Barter PJ, Vrga L, Sullivan DR.
    Atherosclerosis; 1998 Nov 23; 141(1):87-98. PubMed ID: 9863541
    [Abstract] [Full Text] [Related]

  • 27. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I Study Group.
    Diabetes Obes Metab; 2005 Jul 23; 7(4):430-8. PubMed ID: 15955130
    [Abstract] [Full Text] [Related]

  • 28. Treating hypercholesterolaemia with HMG CoA reductase inhibitors: a direct comparison of simvastatin and pravastatin.
    Lintott CJ, Scott RS, Sutherland WH, Bremer J.
    Aust N Z J Med; 1993 Aug 23; 23(4):381-6. PubMed ID: 8240151
    [Abstract] [Full Text] [Related]

  • 29. Effects of pravastatin on exercise electrocardiography test performance and cardiovascular mortality and morbidity in patients with hypercholesterolemia: Lipid Intervention Study in Kyoto.
    Sasaki S, Nakagawa M, Nakata T, Azuma A, Sawada S, Takeda K, Asayama J, Lipid Intrvention Study in Kyoto.
    Circ J; 2002 Jan 23; 66(1):47-52. PubMed ID: 11999665
    [Abstract] [Full Text] [Related]

  • 30. [Erythrocyte fluidity in patients with hyperlipidemia during statins therapy].
    Broncel M, Chojnowska-Jezierska J, Koter-Michalak M, Franiak I.
    Pol Arch Med Wewn; 2005 Jun 23; 113(6):531-7. PubMed ID: 16454441
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial.
    McKenney JM, Jones PH, Adamczyk MA, Cain VA, Bryzinski BS, Blasetto JW, STELLAR Study Group.
    Curr Med Res Opin; 2003 Jun 23; 19(8):689-98. PubMed ID: 14687438
    [Abstract] [Full Text] [Related]

  • 32. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia.
    Glorioso N, Troffa C, Filigheddu F, Dettori F, Soro A, Parpaglia PP, Collatina S, Pahor M.
    Hypertension; 1999 Dec 23; 34(6):1281-6. PubMed ID: 10601131
    [Abstract] [Full Text] [Related]

  • 33. Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.
    Shepherd J, Hunninghake DB, Barter P, McKenney JM, Hutchinson HG.
    Am J Cardiol; 2003 Mar 06; 91(5A):11C-17C; discussion 17C-19C. PubMed ID: 12646338
    [Abstract] [Full Text] [Related]

  • 34. Combination of low-dose niacin and pravastatin improves the lipid profile in diabetic patients without compromising glycemic control.
    Gardner SF, Marx MA, White LM, Granberry MC, Skelton DR, Fonseca VA.
    Ann Pharmacother; 1997 Jun 06; 31(6):677-82. PubMed ID: 9184704
    [Abstract] [Full Text] [Related]

  • 35. Pravastatin in diabetes-associated hypercholesterolemia.
    Rustemeijer C, Schouten JA, Janssens EN, Spooren PF, van Doormaal JJ.
    Acta Diabetol; 1997 Dec 06; 34(4):294-300. PubMed ID: 9451475
    [Abstract] [Full Text] [Related]

  • 36. Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group.
    MacMahon S, Sharpe N, Gamble G, Hart H, Scott J, Simes J, White H.
    Circulation; 1998 May 12; 97(18):1784-90. PubMed ID: 9603532
    [Abstract] [Full Text] [Related]

  • 37. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
    Davidson MH, Testolin LM, Maki KC, von Duvillard S, Drennan KB.
    Arch Intern Med; 1997 Jun 09; 157(11):1186-92. PubMed ID: 9183229
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
    Lewis JH, Mortensen ME, Zweig S, Fusco MJ, Medoff JR, Belder R, Pravastatin in Chronic Liver Disease Study Investigators.
    Hepatology; 2007 Nov 09; 46(5):1453-63. PubMed ID: 17668878
    [Abstract] [Full Text] [Related]

  • 39. Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study.
    Mallon PW, Miller J, Kovacic JC, Kent-Hughes J, Norris R, Samaras K, Feneley MP, Cooper DA, Carr A.
    AIDS; 2006 Apr 24; 20(7):1003-10. PubMed ID: 16603852
    [Abstract] [Full Text] [Related]

  • 40. Effect of hydroxymethylglutaryl-CoA reductase inhibitors on the functional properties of erythrocyte membranes.
    Rabini RA, Polenta M, Staffolani R, Tocchini M, Signore R, Testa I, Mazzanti L.
    Exp Mol Pathol; 1993 Aug 24; 59(1):51-7. PubMed ID: 8262165
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.